Bloomberg Podcasts
@bloombergpodcasts·503K subscribers·32.4K videos
The Weight-Loss Drug Boom’s Prescription Problem | Big Take
Posted
December 23, 2024
Views
431
Likes
6
Engagement
1.39%
December 23, 2024
431
6
1.39%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
15:24Now PlayingDrugs like Ozempic and Wegovy have skyrocketed in popularity over the past few years. To capitalize on that demand, telehealth companies started offering compounded versions of those drugs. That’s made them easier to access, but it’s also introduced new potential risks for people recovering from eating disorders like anorexia.
On today’s Big Take podcast, Bloomberg reporter Madison Muller joins host Sarah Holder to share what she’s learned about the ways telehealth can make it easier for people to get prescriptions that could harm them.
Read moreThe WeightLoss Drug Gold Rush Has a Dangerous Prescription Problem ()
See omnystudio.com/listener () for privacy information.
The Big Take from Bloomberg News brings you inside what’s shaping the world's economies with the smartest and most informed business reporters around the world. The context you need on the stories that can move markets. Every afternoon.
Subscribe to Bloomberg Podcasts
Listen to more of The Big Take
#Bloomberg #Podcast #News #Business #Economy #TheBigTake
Follow Bloomberg Podcasts on Twitter
Visit our other YouTube channels:
Bloomberg Television
Bloomberg Originals
For coverage on news, markets and more
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
